phrykt

Evolus, Inc. (EOLS): who owns it and who trades it

As of Nov 16, 2026, EOLS insiders reported 7 open-market sales worth $1.8M and no purchases in the last 12 months, with 48% of the sale value made under pre-set 10b5-1 plans. The largest seller was David Moatazedi (Director), with $1.7M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Evolus

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns EOLS

157 funds and institutions reported EOLS shares worth $388M at the end of Q2 2026, about 85% of the company. The largest holder is Nantahala Capital Management, LLC with 17.0%.

Funds and institutions (13F) 85%Everyone else 15%

10 largest owners, by share of the company

Nantahala Capital Management, LLC17.0%
BlackRock, Inc.7.4%
Braidwell LP4.8%
Frazier Life Sciences Management, L.P.4.0%
Perceptive Advisors LLC3.7%
Vanguard Capital Management LLC3.6%
Assenagon Asset Management S.A.2.8%
Millennium Management LLC2.7%
State Street Corp2.6%
Geode Capital Management, LLC2.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Nantahala Capital Management, LLC11.20M17.01%$77.8M+76%
BlackRock, Inc.4.84M7.35%$33.6M+13%
Braidwell LP3.16M4.79%$21.9M+2%
Frazier Life Sciences Management, L.P.2.63M3.99%$18.3MNo change
Perceptive Advisors LLC2.46M3.73%$17.1M+91%
Vanguard Capital Management LLC2.36M3.59%$16.4M-4%
Assenagon Asset Management S.A.1.82M2.76%$12.6M+204%
Millennium Management LLC1.79M2.71%$12.4M+22%
State Street Corp1.70M2.58%$11.8M+29%
Geode Capital Management, LLC1.61M2.44%$11.2M+16%
Stonepine Capital Management, LLC1.59M2.41%$11M-10%
Point72 Asset Management, L.P.1.51M2.29%$10.5M–
Pinnacle Associates Ltd1.49M2.26%$10.3M+28%
Armistice Capital, LLC1.44M2.18%$10M+3%
Rice Hall James & Associates, LLC1.29M1.96%$9M+3%
AWH Capital, L.P.1.25M1.90%$8.7M+100%
Goldman Sachs Group Inc1.22M1.85%$8.5M+12%
Soleus Capital Management, L.P.822,4281.25%$5.7M-63%
Soviero Asset Management, LP770,0001.17%$5.3M+13%
UBS Group AG752,6791.14%$5.2MNo change

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, EOLS insiders reported $0 of open-market purchases and $1.8M of sales. 48% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$1.8M
7 trades, 2 people
Sales under a 10b5-1 plan
48%
Share of sale value
Latest trade
Sep 2, 2026
Filed Sep 4, 2026

Purchases and sales by month

$950K$950KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 2, 2026David MoatazediDirectorSale105,108$9.04$950KForm 4
Mar 20, 2026Rui AvelarSee RemarksSale3,119$4.75$14.8KForm 4
Mar 20, 2026David MoatazediDirectorSale plan13,669$4.75$64.9KForm 4
Mar 17, 2026David MoatazediDirectorSale plan116,720$4.89$571KForm 4
Mar 17, 2026Rui AvelarSee RemarksSale plan29,996$4.89$147KForm 4
Dec 22, 2025David MoatazediDirectorSale plan10,539$7.15$75.4KForm 4
Dec 22, 2025Rui AvelarSee RemarksSale plan2,261$7.15$16.2KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
David MoatazediSee Remarks, Director–$1.7MSep 2, 2026
Rui AvelarSee Remarks–$178KMar 20, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

EOLS short interest

Moderate short interest. 9.1% of EOLS shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went down 2%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 6.02M EOLS shares were sold short, 9.1% of the shares outstanding, down 6.0% from the report before. At the average daily volume of 642,143 shares, buying them all back would take about 9.4 trading days (days to cover).

Shares short, % of all shares

9.10%May 15Oct 309.94%

Days to cover

9.4May 15Oct 3010.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20266.02M9.10%-6%642,1439.4
Oct 15, 20266.41M9.70%+14%906,5827.1
Sep 30, 20265.63M8.52%+2%603,4949.3
Sep 15, 20265.53M8.37%+3%837,5736.6
Aug 31, 20265.37M8.13%-8%1.03M5.2
Aug 14, 20265.85M8.86%+5%1.34M4.4
Jul 31, 20265.57M8.43%-6%637,3728.7
Jul 15, 20265.91M8.97%-2%805,8747.3
Jun 30, 20266.02M9.14%+2%824,5757.3
Jun 15, 20265.90M8.95%-3%733,0428.0
May 29, 20266.06M9.20%-2%741,0988.2
May 15, 20266.17M9.37%-7%1.16M5.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Evolus company events

Evolus filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Aug 5, 2026ResultsReleased financial results. Filing
  3. Aug 4, 2026AgreementEvolus Pharma B.V., a wholly owned subsidiary of Evolus, Inc., and Symatese Aesthetics S.A.S. entered into an amendment to the License, Supply and Distribution Agreement dated December 20, 2023, which the Company previously disclosed in a Current Report on Form 8-K filed on December 20, 2023. Filing
  4. Jul 8, 2026AgreementEvolus, Inc. and IBSA Institut Biochimique SA entered into a License, Supply and Distribution Agreement, pursuant to which IBSA granted to the Company an exclusive right and license to develop, commercialize and distribute Profhilo ®, an injectable hyaluronic acid product for skin-quality… Filing
  5. Jun 12, 2026VoteReported shareholder vote results. Filing
  6. May 4, 2026ResultsReleased financial results. Filing
  7. Mar 13, 2026LeadershipDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Filing
  8. Mar 3, 2026AgreementEvolus, Inc. entered into a Loan and Security Agreement with Eclipse Business Capital LLC, as administrative agent and the lenders party thereto. Filing
  9. Jan 9, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Evolus financials

Famous investors that hold EOLS

4 of the 50 well-known investors we track reported holding EOLS in their latest 13F filing. The largest position is Israel Englander's, worth $13.2M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20261.65M$13.2M0.0%-8%
Jim Simons · Renaissance TechnologiesQ3 2026710,596$5.7M0.0%+135%
Ken Griffin · Citadel AdvisorsQ3 202652,384$419K0.0%-90%
Paul Tudor Jones · Tudor Investment CorpQ3 202626,824$215K0.0%-15%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named EOLS in the last 120 days.

FiledHolderFormStake
Nov 9, 2026Soleus Capital Master Fund, L.P.13G/A7.7%
Nov 9, 2026Soleus Capital Master Fund, L.P.13G/A7.7%

Questions about Evolus, Inc. (EOLS) stock

Who owns the most EOLS stock?

The largest reported owner of Evolus, Inc. (EOLS) is Nantahala Capital Management, LLC, with 17.0% of the company. In total, 157 funds and institutions reported holding EOLS at the end of Q2 2026, together about 85% of the shares. See the largest owners.

Are EOLS insiders buying or selling?

In the last 12 months, EOLS insiders reported no open-market purchases and 7 sales worth $1.8M. The latest trade was on Sep 2, 2026. See every trade.

What is the short interest in EOLS?

As of Oct 30, 2026, 6.02M EOLS shares were sold short, 9.1% of the shares outstanding, down 6.0% from the report before. At the average daily volume of 642,143 shares, buying them all back would take about 9.4 trading days (days to cover). See the history.

Which famous investors hold EOLS?

4 of the 50 well-known investors we track reported EOLS in their latest 13F filing, including Israel Englander, Jim Simons, Ken Griffin. The largest position is worth $13.2M. See all holders.

Executive pay

Evolus's chief executive was paid a total of $6.4M for the year ended Dec 31, 2025, down 8% from $7M the year before. In the last 12 months, Evolus's executives and directors bought no stock on the open market and sold $1.8M.

Chief executive, total pay$6.4MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Other top executives, average$2MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.